Evidence map›Paper›PMID 25408905›Full record

ReviewJournal of molecular psychiatry2013

Neuroregeneration and dementia: new treatment options.

Smaranda Ioana Mitran, Bogdan Catalin, Veronica Sfredel, Tudor-Adrian Balseanu

Abstract readReview
In one paragraph

Review in Journal of molecular psychiatry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Total synthesis of jiadifenolide.Angewandte Chemie (International ed. in English) · 2014
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Smaranda Ioana MitranDepartment of Functional Sciences, University of Medicine and Pharmacy, Craiova, Romania ; Center of Clinical and Experimental Medicine, University of Medicine and Pharmacy, Craiova, Romania.
Bogdan CatalinDepartment of Functional Sciences, University of Medicine and Pharmacy, Craiova, Romania ; Center of Clinical and Experimental Medicine, University of Medicine and Pharmacy, Craiova, Romania.
Veronica SfredelDepartment of Functional Sciences, University of Medicine and Pharmacy, Craiova, Romania ; Center of Clinical and Experimental Medicine, University of Medicine and Pharmacy, Craiova, Romania.
Tudor-Adrian BalseanuDepartment of Functional Sciences, University of Medicine and Pharmacy, Craiova, Romania ; Center of Clinical and Experimental Medicine, University of Medicine and Pharmacy, Craiova, Romania ; Physiology Department, University of Medicine and Pharmacy, No 2 Petru Rares street, Craiova, Romania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the last years, physiological aging became a general concept that includes all the changes that occur in organism with old age. It is obvious now, that in developing and developed countries, new health problems concerning older population appear. One of these major concerns is probably dementia. Sooner or later, all forms of dementia lead to learning deficit, memory loss, low attention span, impairment of speech and poor problem solving skills. Normal ageing is a physiological process that also involves a lot of neurological disorders with the same type of symptoms and effects that many researchers are trying to minimize in demented patients. In this review we try to highlight some of the newest aspects of therapeutic strategies that can improve natural neuroregeneration.

Indexed as

AgeingDementiaDementia therapyNeuroregeneration

Identifiers

PMID25408905
PMCPMC4223882

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.